NAT2 and urinary bladder cancer: NAT2 catalyzes both N-acetylation and O-acetylation reactions; modifying carcinogenesis risk with respect to NAT2 genotype, as demonstrated for carcinogens like 4-aminobiphenyl (ABP) in breast and urinary bladder cancer risk10–13.